Research Article

Pituitary Stalk Germ Cell Tumors: Retrospective Case Series and Literature Review

Table 2

Neuroendocrine disturbance of the patients.

No.PatientNeuroendocrine disturbance
Pre-CRTPost-CRTFinal follow-up (age/year)

116MCDI, HPA, HPRL, and GH/IGFCDI, HPRL, and GH/IGFCDI and GH/IGF (21)
26MCDICDICDI (11)
38MCDI and HPRLCDICDI (11)
413MCDI, GH/IGF, and HPRLCDI, GH/IGF, HPG, and HPRLCDI, GH/IGF, HPG, HPT, and HPRL (15)
513FCDI, GH/IGF, and HPGCDI, GH/IGF, and HPGCDI, GH/IGF, and HPG (15)
69FCDI and HPRLCDICDI (11)
75MCDICDICDI (7)
812FCDI and GH/IGFCDI and GH/IGFCDI, GH/IGF, and HPG (14)
912MCDI and HPRLCDICDI (14)
1017FCDI, GH/IGF, and HPGCDI and GH/IGFCDI (18)
115MCDI, GH/IGF, and HPRLCDI and GH/IGF-

Patient: M, male; F, female; neuroendocrine disturbance: CDI, central diabetes insipidus; HPA, hypothalamic pituitary adrenal axis; HPG, hypothalamic pituitary gonadal axis; HPT, hypothalamic pituitary thyroid axis; HPRL, hyperprolactinemia, GH/IGF, growth hormone/insulin-like growth factor axis; CRT, chemoradiotherapy.